Bill Text: TX HR1554 | 2019-2020 | 86th Legislature | Enrolled
Bill Title: Congratulating Dr. David Wang on being named the VA North Texas Health Care System's 2019 Researcher of the Year.
Spectrum: Partisan Bill (Democrat 1-0)
Status: (Passed) 2019-05-16 - Reported enrolled [HR1554 Detail]
Download: Texas-2019-HR1554-Enrolled.html
H.R. No. 1554 |
|
||
WHEREAS, Dr. David Wang is being honored by the VA North | ||
Texas Health Care System as its Researcher of the Year on May 16, | ||
2019; and | ||
WHEREAS, Dr. Wang serves as a staff medical oncologist for | ||
the VA North Texas Health Care System as well as an associate | ||
professor of internal medicine at The University of Texas | ||
Southwestern Medical Center in Dallas; he holds an undergraduate | ||
degree from Asbury College, a medical degree from Vanderbilt | ||
University, and a graduate degree in cellular and molecular | ||
medicine from Johns Hopkins University; while in medical school, he | ||
was selected as a Howard Hughes Medical Institute-National | ||
Institutes of Health Research Scholar, and he notably performed | ||
research at the National Cancer Institute; he went on to complete | ||
his residency in internal medicine on the Osler Medical Service of | ||
Johns Hopkins and his medical oncology fellowship at the Sidney | ||
Kimmel Comprehensive Cancer Center at Johns Hopkins; and | ||
WHEREAS, Among his most significant accomplishments, | ||
Dr. Wang has been part of a lab group that has made breakthroughs in | ||
understanding Barrett's esophagus, a condition that can be a | ||
precursor to esophageal cancer; his lab has also focused its | ||
research efforts on developing biomarkers and molecularly targeted | ||
therapy strategies for esophageal cancer; these studies have been | ||
funded by grants awarded by the U.S. Department of Veterans | ||
Affairs, the American Cancer Society, and the National Institutes | ||
of Health; and | ||
WHEREAS, As a clinically active oncologist, Dr. Wang was | ||
instrumental in establishing a multidisciplinary GI malignancy | ||
clinic at the Dallas VA Medical Center, and he serves as the | ||
principal investigator for many of its clinical trials; he is also | ||
the oncology team leader for the UT Southwestern Esophageal | ||
Diseases Center, a member of the national VA GI Clinical Trials | ||
Steering Committee, and a member of the Via Pathways GI Cancer | ||
clinical guidelines panel; his other professional affiliations | ||
include the American Gastroenterological Association, the American | ||
Association for Cancer Research, and the American Society of | ||
Clinical Oncology; and | ||
WHEREAS, Dr. David Wang has distinguished himself through | ||
his professional achievements and his commitment to the advancement | ||
of research with lifesaving potential, and his efforts have | ||
contributed greatly to the mission of the VA North Texas Health Care | ||
System; now, therefore, be it | ||
RESOLVED, That the House of Representatives of the 86th Texas | ||
Legislature hereby congratulate Dr. David Wang on being named the | ||
VA North Texas Health Care System's 2019 Researcher of the Year and | ||
extend to him sincere best wishes for continued success with his | ||
important work; and, be it further | ||
RESOLVED, That an official copy of this resolution be | ||
prepared for Dr. Wang as an expression of high regard by the Texas | ||
House of Representatives. | ||
Sherman, Sr. | ||
______________________________ | ||
Speaker of the House | ||
I certify that H.R. No. 1554 was adopted by the House on May | ||
14, 2019, by a non-record vote. | ||
______________________________ | ||
Chief Clerk of the House | ||